OPKO Health, Inc. Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
OPKO Health, Inc. (OPK) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $7.66 million as of 2014-12-31, per its 10-K filed 2015-02-27.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2015-02-27
- 2014-12-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $7.66M.
- 2014-09-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $7.76M.
- 2014-06-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $9.54M.
- 2014-03-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $8.15M.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) |
|---|---|
| 2014-12-31 | $7.66M 10-K · filed 2015-02-27 |
| 2014-09-30 | $7.76M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $9.54M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $8.15M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $9.06M 10-K · filed 2015-02-27 |
| 2013-09-30 | $11.40M 10-Q · filed 2013-11-12 |
| 2012-12-31 | $15.20M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |